Protective mutations associated with APOE in Alzheimer's disease

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder with increasing global incidence.
• The Apolipoprotein E (APOE) gene, particularly the APOE4 allele, is a major genetic risk factor for sporadic AD.
• Identifying protective genetic variants is crucial for developing effective AD treatments.

Purpose of the Study:

• To comprehensively review the protective effects of APOE gene variants and mutations in Alzheimer's disease.
• To explore the cellular impact of these protective variants during AD pathogenesis.
• To compile new therapeutic insights offered by protective APOE mutations for advanced treatment strategies.

Main Methods:

• Literature review focusing on APOE gene, its variants, and Alzheimer's disease.
• Analysis of cellular mechanisms affected by protective APOE mutations.
• Compilation of potential therapeutic applications, including gene editing, RNA editing, and stem cell therapy.

Main Results:

• APOE variants, beyond the risk-associated APOE4, demonstrate protective effects against AD.
• Protective APOE variants influence cellular pathways involved in AD pathology.
• These variants offer novel targets and strategies for AD treatment development.

Conclusions:

• Protective APOE variants represent a significant area for AD research and therapeutic development.
• Understanding their cellular impact can guide the design of innovative treatments.
• APOE-targeted therapies, including gene and stem cell approaches, hold promise for managing Alzheimer's disease.